Central nervous system effects from a peripherally acting cholinesterase inhibiting agent: interaction with stress or genetics

Ann N Y Acad Sci. 2001 Mar:933:310-4. doi: 10.1111/j.1749-6632.2001.tb05833.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Acetylcholine / metabolism*
  • Acetylcholinesterase / drug effects
  • Animals
  • Basal Ganglia / drug effects
  • Basal Ganglia / enzymology
  • Behavior, Animal / drug effects
  • Brain Chemistry / drug effects*
  • Cholinesterase Inhibitors / adverse effects
  • Cholinesterase Inhibitors / pharmacology
  • Cholinesterase Inhibitors / toxicity*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Resistance / genetics
  • Electroshock
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Muscle Contraction / drug effects
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Persian Gulf Syndrome / chemically induced
  • Persian Gulf Syndrome / physiopathology
  • Prosencephalon / drug effects
  • Prosencephalon / enzymology
  • Pyridostigmine Bromide / adverse effects
  • Pyridostigmine Bromide / pharmacology
  • Pyridostigmine Bromide / toxicity*
  • Rats
  • Rats, Inbred WKY
  • Rats, Sprague-Dawley
  • Salivation / drug effects
  • Stress, Physiological / genetics
  • Stress, Physiological / metabolism*

Substances

  • Cholinesterase Inhibitors
  • Nerve Tissue Proteins
  • Acetylcholinesterase
  • Pyridostigmine Bromide
  • Acetylcholine